NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » Digital therapeutics provider Biofourmis secures $100m in series C funding » digital

Digital therapeutics provider Biofourmis secures $100m in series C funding

NS Medical Devices is using cookies

Digital therapeutics provider Biofourmis has secured $100m in series C funding. (Credit: Emilian Danaila from Pixabay)

Related Article

Biggest players in the global wound care market

RECOMMENDED COMPANIES

MOST READ

Blue Arbor secures FDA Breakthrough Device Designation for RESTORE System

Angle partners with AstraZeneca to develop advanced cancer assay

United Therapeutics conducts first transplant of UThymoKidney

RenovaroCube to fully acquire molecular biology firm Cyclomics

Exo introduces new cardiac and lung AI applications on Exo Iris

Recommended Whitepaper